Forian Inc
NASDAQ:FORA
Intrinsic Value
Forian, Inc. engages in the provision of healthcare information, analytics and technology services. [ Read More ]
The intrinsic value of one FORA stock under the Base Case scenario is 2.58 USD. Compared to the current market price of 2.72 USD, Forian Inc is Overvalued by 5%.
Valuation Backtest
Forian Inc
Run backtest to discover the historical profit from buying and selling FORA stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Forian Inc
Current Assets | 57.3m |
Cash & Short-Term Investments | 48.3m |
Receivables | 3.7m |
Other Current Assets | 5.2m |
Non-Current Assets | 1.6m |
PP&E | 86.8k |
Other Non-Current Assets | 1.5m |
Current Liabilities | 6.8m |
Accounts Payable | 161.6k |
Accrued Liabilities | 4.3m |
Other Current Liabilities | 2.4m |
Non-Current Liabilities | 25.9m |
Long-Term Debt | 24.9m |
Other Non-Current Liabilities | 1m |
Earnings Waterfall
Forian Inc
Revenue
|
20.5m
USD
|
Cost of Revenue
|
-5.5m
USD
|
Gross Profit
|
15m
USD
|
Operating Expenses
|
-20.3m
USD
|
Operating Income
|
-5.3m
USD
|
Other Expenses
|
16.5m
USD
|
Net Income
|
11.1m
USD
|
Free Cash Flow Analysis
Forian Inc
FORA Profitability Score
Profitability Due Diligence
Forian Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
Score
Forian Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
FORA Solvency Score
Solvency Due Diligence
Forian Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Score
Forian Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FORA Price Targets Summary
Forian Inc
According to Wall Street analysts, the average 1-year price target for FORA is 4.85 USD with a low forecast of 4.55 USD and a high forecast of 5.25 USD.
Ownership
FORA Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
FORA Price
Forian Inc
Average Annual Return | -67.78% |
Standard Deviation of Annual Returns | 7.11% |
Max Drawdown | -91% |
Market Capitalization | 84.1m USD |
Shares Outstanding | 30 975 500 |
Percentage of Shares Shorted | 0.97% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The company is headquartered in Newtown, Pennsylvania and currently employs 138 full-time employees. The company went IPO on 2021-03-03. The firm provides software solutions, data and predictive analytics to optimize the operational, clinical and financial performance of its healthcare, cannabis, and government customers. Its BioTrack vertically integrated point-of-sale, manufacturing, delivery and cultivator software solution is a commercial platform in the cannabis industry, serving dispensaries, cultivators, manufacturers and distributors within 38 states and Puerto Rico. Its Cannalytics software as a service (SaaS)-based analytics solution is a platform that provides clients with a configurable and flexible presentation of business performance. Its real world experience (RWE) solutions are designed to enable the integration otherwise unconnected and disparate data to enable near real-time surveillance of adverse events and to study the clinical economic and social impacts of various therapeutic alternatives, including those derived from cannabinoids and psychedelics.
Contact
IPO
Employees
Officers
The intrinsic value of one FORA stock under the Base Case scenario is 2.58 USD.
Compared to the current market price of 2.72 USD, Forian Inc is Overvalued by 5%.